PGY-2 Infectious Diseases Residency


PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.

Additional Program Description

The Postgraduate Year Two (PGY2) Infectious Diseases Pharmacy Residency Program is designed to develop accountability; practice patterns; habits; and expert knowledge, skills, attitudes, and abilities in the respective advanced area of pharmacy practice. The Infectious Diseases Pharmacy Residency Program builds upon the broad-based competencies achieved in a PGY1 residency, deepening the resident's ability to provide care in the most complex of cases or in the support of care through practice leadership. Therefore, the Infectious Diseases Pharmacy Residency Program provides residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and transforming both into improved medication therapy for patients. A resident who successfully completes the PGY2 Infectious Diseases Pharmacy Residency Program should be prepared to enter into a clinical practice position in a hospital-based environment or a combination of academia and practice affiliated with a College of Pharmacy. They should also possess the competencies that enable attainment of board certification in the practice area (i.e., Board Certified Infectious Diseases Pharmacist).

The Infectious Diseases pharmacy residency at the Medical University of South Carolina (MUSC) Health is a specialized residency consisting of 12 months of training and experience in various practice areas in infectious diseases, antimicrobial stewardship (ASP), and immunocompromised hosts. The program allows sufficient flexibility to adapt to the interests and needs of the individual resident, yet provides the basic foundation for quality clinical practice in infectious diseases. The resident will have the opportunity to gain clinical, research, and teaching experience in infectious diseases. Upon completion of this comprehensive program, the resident will be prepared to enter a clinical practice position or a fellowship program.

Goals of the Residency

Specific residency goals and objectives will be established in the beginning of the residency modified according to the resident's interests and previous experiences and advisor input. To meet the purpose of the residency, the resident will advance to achieve the following outcomes:

  • Serve as an authoritative resource on the optimal use of medications in patients with infectious diseases.
  • Optimize the outcomes of infectious diseases patients by promoting and/or providing evidence-based medication therapy as an integral member of an interdisciplinary team in acute and ambulatory care settings.
  • Optimizing clinical outcomes while minimizing unintended consequences of antimicrobial use through antimicrobial stewardship.
  • Manage and improve the medication-use process in patients with known or suspected infectious diseases.
  • Demonstrate leadership and practice management skills.
  • Demonstrate excellence in the provision of training or educational activities about anti-infective agents for health care professionals and health care professionals in training.
  • Conduct research and contribute to the medical literature in the infectious diseases arena.
  • Contribute to formulary decisions regarding anti-infective agents and participate on the Anti-infective Subcommittee of the Pharmacy and Therapeutics Committee.
  • Demonstrate skills required to function in an academic setting.

Program Design

The resident will have the opportunity to gain clinical, research, and teaching experience in infectious diseases. The breadth of experience provided by this residency program will allow successful candidates to work in any facet of infectious diseases. The residency is designed to provide a diverse experience, while focusing on the needs of the individual resident. Residents may tailor elective rotations to meet their particular goals and career needs. In addition to month-long rotations, residents will have several longitudinal experiences including staffing, HIV/ID clinic, and adult on-call. Residents are provided with formal written evaluations following each monthly rotation in order to provide for an optimal experience. Residents will complete a quarterly self-evaluation to assure compliance with self-determined goals and the ASHP Residency Learning System. The resident must have previously completed a pharmacy practice residency or have an equivalent level of experience in hospital pharmacy practice prior to entering this specialized residency program.


Required core rotations for 1 to 3 months are available in the following areas:

  • Adult Infectious Diseases Consult Service 2-3 months
  • Antimicrobial Stewardship Service 2-3 months
  • Transplant Infectious Diseases Consult Service 1 month
  • Pediatric Antimicrobial Stewardship/Infectious Diseases Consult 1 month
  • HIV Clinic 1 month
  • Microbiology Lab 1 month
  • Internal Medicine 1 month
  • Research 1 month
  • Electives* 2 months

*Electives include, but are not limited to, the following month long rotations:

  •  Critical Care (MICU, MSICU, STBICU, CTICU)
  • Internal Medicine
  • Pulmonary/NTM Clinic (can be longitudinal)
  • Medication Use Policy and Informatics
  • Emergency Medicine

Adult On-Call

The adult on-call experience is a 24-hour program that allows for PGY2 residents to refine their knowledge base and become proficient in, but not limited to, the following areas: time management, drug information search strategies and literature evaluation, communication, pharmacokinetics, and antibiotic initiation and follow up.


The residents will staff a mixture of decentralized and ASP on-call on a monthly basis. Shifts and schedules may vary based on duty hours, but will not exceed an average of 16 hours/month.


  • Primary Research Project
  • Medication Use Evaluation (MUE)
  • Miscellaneous

Committee Involvement

  • Anti-Infective Subcommittee (AISC) - required
  • Miscellaneous

Didactic Teaching and Preceptorship

  • Teaching certificate programming available through the Academic Preparation Program (APP)
  • Didactic lectures in infectious diseases related areas within the college of pharmacy
  • In-services to pharmacy, medical, and nursing staff (inpatient and outpatient)
  • Co-preceptor of PharmD students and PGY1 residents on rotations
  • Core Disease-specific Index
  • Bone and joint infections
  • Cardiovascular infections
  • Central nervous system infections
  • Fever of unknown origin
  • Fungal infections
  • Gastrointestinal infections
  • Hepatitis B
  • Hepatitis C
  • HIV-infection and AIDS
  • Intra-abdominal infections
  • Neutropenic fever
  • Ophthalmologic infections
  • Opportunistic infections in immunocompromised hosts
  • Parasitic infections
  • Reproductive organ infections
  • Respiratory infections: upper and lower
  • Rickettsial infections
  • Sepsis
  • Sexually transmitted diseases
  • Skin and soft tissue infections
  • Tuberculosis and other mycobacterial Infections
  • Travel medicine
  • Urologic infections
  • Viral infections

Core Preceptors

  • Infectious Diseases/Antimicrobial Stewardship
    • Krutika Mediwala Hornback, PharmD, BCPS, BCIDP; Clinical Pharmacy Specialist, Infectious Diseases/Antimicrobial Stewardship;
    • Rachel F. Burgoon, PharmD; Clinical Pharmacy Specialist, Infectious Diseases/Antimicrobial Stewardship;
    • Aaron C. Hamby, PharmD; Clinical Pharmacy Specialist, Infectious Diseases/Antimicrobial Stewardship – Tele-ASP;
    • Taylor Morrisette, PharmD, MPH; Clinical Pharmacy Specialist, Infectious Diseases/Antimicrobial Stewardship – Pediatrics;
  • Microbiology
  • Adult On-Call/Critical Care
    • Carolyn Magee Bell, PharmD, BCCCP; Clinical Pharmacy Specialist, MSICU;
  • Longitudinal and/or Monthly Clinic
    • Wendy Bullington, PharmD, BCPS; Clinical Pharmacy Specialist, Pulmonary/NTM Clinic;
    • Stephanie Kirk, PharmD, CDCES, BCACP, AAHIVP; Clinical Pharmacy Specialist – HIV Clinic;
  • Internal Medicine
    • Lindsay Deloney, PharmD, BCPS; Clinical Pharmacy Specialist – Internal Medicine;

Requirements for Program

Completion See Appendix A in our Residency Manual.